Immunology Medical Research Clinical Trials Clinical Trials Cell Biology Immunology Oncology Disease Prevention Pharmacology Clinical Studies
It leverages CRISPR/Cas9 disruption of the interferon-γ receptor to boost CAR-T cell durability ahead of planned solid tumor trials.